» Articles » PMID: 23312620

Different Sizes of Centrilobular Ground-glass Opacities in Chest High-resolution Computed Tomography of Patients with Pulmonary Veno-occlusive Disease and Patients with Pulmonary Capillary Hemangiomatosis

Abstract

Background: Centrilobular ground-glass opacity (GGO) is one of the characteristic findings in chest high-resolution computed tomography (HRCT) of patients with pulmonary veno-occlusive disease (PVOD) and patients with pulmonary capillary hemangiomatosis (PCH). However, clinical differential diagnosis of these two diseases is difficult and has not been established. In order to clarify their differences, we compared the sizes of GGOs in chest HRCT and the sizes of capillary assemblies in pulmonary vascular casts between patients diagnosed pathologically with PVOD and PCH.

Methods: We evaluated chest HRCT images for four patients with idiopathic pulmonary arterial hypertension (IPAH), three patients with PVOD and three patients with PCH, and we evaluated pulmonary vascular casts of lung tissues obtained from those patients at lung transplantation or autopsy.

Results: Centrilobular GGOs in chest HRCT were observed in patients with PVOD and patients with PCH but not in patients with IPAH. We measured the longest diameter of the GGOs. The size of centrilobular GGOs was significantly larger in patients with PCH than in patients with PVOD (5.60±1.43 mm versus 2.51±0.79 mm, P<.01). We succeeded in visualization of the 3-dimensional structures of pulmonary capillary vessels obtained from the same patients with PVOD and PCH undergoing lung transplantation or autopsy and measured the diameters of capillary assemblies. The longest diameter of capillary assemblies was also significantly larger in patients with PCH than in patients with PVOD (5.44±1.71 mm versus 3.07±1.07 mm, P<.01).

Conclusion: Measurement of the sizes of centrilobular GGOs in HRCT is a simple and useful method for clinical differential diagnosis of PVOD and PCH.

Citing Articles

Different clinicopathological features between young and older patients with pulmonary adenocarcinoma and ground-glass opacity.

Lu X, Chen Y, Li Y, Tang M, Zheng X Sci Rep. 2024; 14(1):15679.

PMID: 38977890 PMC: 11231279. DOI: 10.1038/s41598-024-66910-4.


Comparison of Clinical and Pathological Characteristics Between Extremely Multiple GGNs and Single GGNs.

Wang X, Wu M, Shen H, Nie Y, Zhang K, Wei Z Front Oncol. 2021; 11:725475.

PMID: 34621675 PMC: 8490711. DOI: 10.3389/fonc.2021.725475.


Pulmonary capillary hemangiomatosis-predominant vasculopathy in a patient with rheumatoid arthritis-associated interstitial lung disease: An autopsy report.

Nakamura J, Tsujino I, Yamamoto G, Nakaya T, Takahashi K, Kimura H Respir Med Case Rep. 2020; 31:101215.

PMID: 33024689 PMC: 7527749. DOI: 10.1016/j.rmcr.2020.101215.


Emerging role of cardiovascular magnetic resonance imaging in the management of pulmonary hypertension.

Aryal S, Sharifov O, Lloyd S Eur Respir Rev. 2020; 29(156).

PMID: 32620585 PMC: 9488921. DOI: 10.1183/16000617.0138-2019.


Pulmonary capillary haemangiomatosis: a distinct entity?.

Weatherald J, Dorfmuller P, Perros F, Ghigna M, Girerd B, Humbert M Eur Respir Rev. 2020; 29(156).

PMID: 32461209 PMC: 9488541. DOI: 10.1183/16000617.0168-2019.